Fresenius Medical Care AG & Co. KGaA Market Share Analysis
Summary
GlobalData’s new report, “Fresenius Medical Care AG & Co. KGaA Market Share Analysis” provides in-depth information on Fresenius Medical Care AG & Co. KGaA’s market position in the different medical equipment markets it operates in. The report provides Fresenius Medical Care AG & Co. KGaA market share information in one key market category – Renal Dialysis Equipment. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Global company shares (in Revenues) information for the key markets Fresenius Medical Care AG & Co. KGaA operates in – Nephrology and Urology Devices.
- Fresenius Medical Care AG & Co. KGaA’s company shares (in Revenues) information for all the key countries the company has presence in – China, Australia, India, Japan, Germany, France, Spain, United Kingdom, Italy, Canada, United States and Brazil.
- Fresenius Medical Care AG & Co. KGaA’s company shares (in Revenues) information for all the key market category the company has presence in – Renal Dialysis Equipment.
- All the key data-points are for 2011 and cover all the key regions – North America, Europe, Asia-Pacific, South and Central America and Middle East and Africa.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.
Reasons to buy
- Develop sales and marketing strategies by identifying who-stands-where in the markets, Fresenius Medical Care AG & Co. KGaA operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Fresenius Medical Care AG & Co. KGaA’s market positions.
Global Managed Care Industry
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets/Categories Covered 10
3.1 Nephrology and Urology Devices 10
3.1.1 Renal Dialysis Equipment 10
4 Company Snapshot 11
4.1 Key Facts 11
4.2 Company Overview 11
4.3 Financial Performance 11
4.4 SWOT Snapshot 11
5 Business Description 12
5.1 Business Overview 12
5.2 Dialysis Products 12
5.2.1 Overview 12
5.2.2 Financials 12
5.3 Dialysis Services 13
5.3.1 Overview 13
5.3.2 Financials 13
5.3.3 Market View 13
5.4 Major Products and Services 13
5.4.1 Overview 13
6 History 15
7 SWOT Analysis 18
7.1 Overview 18
7.2 Fresenius Medical Care AG & Co. KGaA Strengths 18
7.2.1 Strong Cash Reserves 18
7.2.2 Vertically Integrated Operations 19
7.2.3 Financial Performance 19
7.2.4 Worldwide Manufacturing Facilities 19
7.2.5 Leading Market Position 20
7.3 Fresenius Medical Care AG & Co. KGaA Weaknesses 20
7.3.1 Reliance on Referrals 20
7.3.2 Product Recalls 20
7.3.3 Revenue Concentration 20
7.4 Fresenius Medical Care AG & Co. KGaA Opportunities 21
7.4.1 Expanding Peritoneal Dialysis Market 21
7.4.2 Regulatory Support 21
7.4.3 Expansion in High Growth Markets 21
7.4.4 Growing Incidence of End-Stage Renal Disease 21
7.4.5 Partnership and Agreements 22
7.4.6 Inorganic Growth: Strategic Acquisitions 22
7.5 Fresenius Medical Care AG & Co. KGaA Threats 23
7.5.1 Rapid Technological Change 23
7.5.2 Risk of Infection 23
7.5.3 Cost Containment Pressures 23
7.5.4 Stringent Regulations 23
7.5.5 Intense Competition 23
8 Competitors 24
9 Competitive Landscape 25
9.1 Nephrology and Urology Devices (Renal Dialysis Equipment), Global, Market Share (%), 2011 25
9.2 Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices (Renal Dialysis Equipment), by Region, Market Share (2011) 27
9.3 Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices (Renal Dialysis Equipment), by Country, Market Share (2011) 29
10 Key Employees 31
11 Key Employee Biographies 32
12 Company Statement 33
13 Locations And Subsidiaries 35
13.1 Head Office 35
13.2 Other Locations & Subsidiaries 35
14 Financial Deals Landscape 37
14.1 Fresenius Medical Care AG & Co. KGaA, Deals Volume Summary, 2006 to YTD 2012 37
15 Fresenius Medical Care AG & Co. KGaA Detailed Deal Summary 39
15.1 Asset Purchase 39
15.1.1 Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International 39
15.1.2 Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics 41
15.1.3 Fresenius Medical Care Acquires Worldwide Peritoneal Dialysis Business From Gambro 42
15.1.4 Fresenius Medical Care Canada Acquires Rights For NephroCare Software From Cybernius Medical 44
15.1.5 Fresenius Medical Care Acquires Dialysis Stations From Hand Prod 45
15.1.6 Fresenius Medical Care Acquires 11 Dialysis Clinics 46
15.2 Partnerships 47
15.2.1 Interface Biologics Enters Into Licensing Agreement With Fresenius Medical Care 47
15.2.2 Fresenius Medical Care Enters Into An Agreement With NIKKISO 48
15.2.3 BTG International Enters Into A Licensing Agreement With Fresenius Medical Care 49
15.2.4 Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For $800 Million 50
15.2.5 Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For $316.4 Million 51
15.2.6 Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For $700 Million 52
15.2.7 Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For $133.7 Million 53
15.2.8 Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For $550 Million 54
15.2.9 Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For $400 Million 55
15.2.10 Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For $650 Million 56
15.2.11 Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For $403 Million 57
15.2.12 Fresenius Medical Care Completes Private Placement Of Senior Notes For $360.42 Million 59
15.2.13 Fresenius Medical Care Completes Private Placement Of $500 Million 60
15.3 Acquisition 61
15.3.1 Fresenius Medical Care Acquires HIT Services Group 61
15.3.2 Fresenius Medical Acquires Renal Solutions 62
16 Recent Developments 63
16.1 Strategy And Business Planning 63
16.1.1 Dec 22, 2011: Fresenius Medical Care Enters Dialysis Services Market In Ecuador 63
16.1.2 Nov 03, 2011: Fresenius Medical Selects ViryaNet’s G4 Workforce Management Solution 63
16.1.3 Jul 23, 2010: Fresenius Medical Care Enters Into Long-Term Distribution Agreement In Japan And Expands Dialysis Products Business In Korea 64
16.1.4 Mar 06, 2008: Fresenius Expands Dialyzer Production Capacity In Germany 64
16.2 Financial Announcements 65
16.2.1 Feb 21, 2012: Fresenius Medical Reports Revenue Of $12.8 Billion In 2011 65
16.2.2 Nov 02, 2011: Fresenius Medical Reports Revenues Of $3.2 Billion In Q3 2011 67
16.2.3 Aug 02, 2011: Fresenius Medical Reports Total Net Revenue Of $3.2 Billion In Q2 2011 69
16.2.4 May 04, 2011: Fresenius Medical Reports Net Revenue Of $3 Billion In Q1 2011 70
16.2.5 Feb 23, 2011: Fresenius Medical Reports Total Net Revenues Of $12 Billion In 2010 71
16.2.6 Nov 02, 2010: Fresenius Medical Reports Total Net Revenue Of $3.1 Billion In Q3 2010 72
16.2.7 Aug 03, 2010: Fresenius Medical Reports Total Net Revenues Of $2.9 Billion In Q2 2010 74
16.2.8 May 04, 2010: Fresenius Medical Reports Net Revenues Of $2.9 Billion In Q1 2010 75
16.2.9 Feb 24, 2010: Fresenius Medical Reports Net Income Of $891 Million In 2009 78
16.2.10 Nov 03, 2009: Fresenius Medical Reports Net Income Of $244.5 million In Q3 2009 80
16.2.11 Aug 04, 2009: Fresenius Medical Reports Net Income Of $239.03 Million In Q2 2009 82
16.2.12 Apr 30, 2009: Fresenius Medical Posts Net Income Of $198 Million In Q1 2009 84
16.2.13 Feb 19, 2009: Fresenius Medical Reports 2008 Results 86
16.2.14 Nov 04, 2008: Fresenius Medical Reports 3Q 2008 Results 88
16.2.15 Jul 17, 2008: Fresenius Medical Reports Preliminary 2Q 2008 Results 90
16.2.16 May 20, 2008: Fresenius Medical Provides Revenue Guidance For Remainder Of 2008 90
16.2.17 Apr 30, 2008: Fresenius Medical Declares Q1 2008 Results 91
16.2.18 Feb 20, 2008: Fresenius Medical Declares Q4 2007 Results 91
16.2.19 Oct 31, 2007: Fresenius Medical Declares Q3 2007 Results 93
16.2.20 Aug 02, 2007: Fresenius Medical Declares Q2 2007 Results 93
16.2.21 May 15, 2007: Fresenius Medical Announces Share Split Approval 94
16.2.22 May 02, 2007: Fresenius Medical Declares Q1 2007 Results 95
16.2.23 Feb 22, 2007: Fresenius Medical Declares Q4 2006 Results 95
16.2.24 Oct 31, 2006: Fresenius Medical Declares Q3 2006 Results 96
16.3 Research And Development 97
16.3.1 May 05, 2009: Fresenius Opens Dialysis Clinic In Sweden 97
16.4 Corporate Communications 97
16.4.1 Dec 09, 2009: Fresenius Medical Care Announces Management Board Changes 97
16.4.2 Mar 10, 2009: Fresenius Medical CFO Resigns 99
16.5 Legal and Regulatory 100
16.5.1 Sep 17, 2009: Appeals Court Remands Patent Case Between Baxter And Fresenius 100
16.5.2 May 06, 2009: Fresenius Medical Announces Completion Of Government Investigation 100
16.6 Government and Public Interest 100
16.6.1 Feb 10, 2012: Aetna And Fresenius Medical Care Begin Chronic Kidney Disease Management Program 100
16.6.2 Mar 17, 2011: Fresenius Medical Care Patient Safety Organization Secures US Certification 101
16.6.3 Mar 17, 2011: Fresenius Medical Care’s Patient Safety Organization Receives Official Certification From US Department of Health & Human Services 102
16.7 Product News 103
16.7.1 Nov 18, 2010: Fresenius Introduces 2008T Hemodialysis Delivery System At Renal Week 2010 103
16.8 Other Significant Developments 103
16.8.1 Jan 19, 2011: Fresenius Medical Care Wins Contract For Comprehensive Dialysis Care And Performance-Oriented Reimbursement In Spain 103
17 Appendix 104
17.1 Research Methodology 105
17.2 Secondary Research 105
17.3 Primary Research 105
17.4 Models 106
17.5 Forecasts 106
17.6 Expert Panels 106
17.7 GlobalData Consulting 106
17.8 Currency Conversion 107
17.9 Contact Us 108
17.10 Disclaimer 108
List of Tables
Table 1: Fresenius Medical Care AG & Co. KGaA, Key Facts, 2011 11
Table 2: Fresenius Medical Care AG & Co. KGaA, SWOT Analysis, 2011 18
Table 3: Nephrology and Urology Devices (Renal Dialysis Equipment), Global, Company Share by Revenue ($m), 2011 26
Table 4: Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices (Renal Dialysis Equipment), by Region, Revenue ($m) and Market Share (%), 2011 28
Table 5: Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices, (Renal Dialysis Equipment) by Country, Revenue ($m) and Market Share (%), 2011 30
Table 6: Fresenius Medical Care AG & Co. KGaA, Key Employees 31
Table 7: Fresenius Medical Care AG & Co. KGaA, Other Locations 35
Table 8: Fresenius Medical Care AG & Co. KGaA, Subsidiaries 36
Table 9: Fresenius Medical Care AG & Co. KGaA, Deals Volume Summary, 2006 to YTD 2012 37
Table 10: Fresenius Medical Care AG & Co. KGaA, Deals Summary, 2006 to YTD 2012 38
Table 11: Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International 39
Table 12: Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics 41
Table 13: Fresenius Medical Care Acquires Worldwide Peritoneal Dialysis Business From Gambro 42
Table 14: Fresenius Medical Care Canada Acquires Rights For NephroCare Software From Cybernius Medical 44
Table 15: Fresenius Medical Care Acquires Dialysis Stations From Hand Prod 45
Table 16: Fresenius Medical Care Acquires 11 Dialysis Clinics 46
Table 17: Interface Biologics Enters Into Licensing Agreement With Fresenius Medical Care 47
Table 18: Fresenius Medical Care Enters Into An Agreement With NIKKISO 48
Table 19: BTG International Enters Into A Licensing Agreement With Fresenius Medical Care 49
Table 20: Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For $800 Million 50
Table 21: Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For $316.4 Million 51
Table 22: Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For $700 Million 52
Table 23: Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For $133.7 Million 53
Table 24: Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For $550 Million 54
Table 25: Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For $400 Million 55
Table 26: Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For $650 Million 56
Table 27: Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For $403 Million 57
Table 28: Fresenius Medical Care Completes Private Placement Of Senior Notes For $360.42 Million 59
Table 29: Fresenius Medical Care Completes Private Placement Of $500 Million 60
Table 30: Fresenius Medical Care Acquires HIT Services Group 61
Table 31: Fresenius Medical Acquires Renal Solutions 62
Table 32: USD to Local Currency, Average Exchange Rate, 2011 107
List of Figures
Figure 1: Nephrology and Urology Devices (Renal Dialysis Equipment), Global, Market Share (%), 2011 25
Figure 2: Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices (Renal Dialysis Equipment), by Region, Market Share (%), 2011 27
Figure 3: Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices (Renal Dialysis Equipment), by Country, Market Share (%), 2011 29
Figure 4: Fresenius Medical Care AG & Co. KGaA, Deals Volume Summary, 2006 to YTD 2012 37
Companies mentioned
Baxter International Inc.
Gambro AB
B. Braun Melsungen AG
Nipro Corporation
Asahi Kasei Corporation
NIKKISO CO., LTD.
NxStage Medical, Inc.
Bellco Srl
Dialysis Clinics Inc.
Diaverum AB
DaVita Inc.
The Dialysis Clinic Inc.
Renal Advantage Inc.
Kawasumi Lab
